Bernstein downgrades Summit Therapeutics stock rating on trial concerns

Markets Investing.com By Investing.com 21 May 2026 21:29 1 min read

Bernstein downgrades Summit Therapeutics stock rating on trial concerns

Bernstein downgrades Summit Therapeutics stock rating on trial concerns

Bernstein downgrades Summit Therapeutics stock rating on trial concerns

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.